Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Health-Related Quality of Life, Depression and Anxiety in Hospitalized Patients with Tuberculosis

  • Received : 2016.06.14
  • Accepted : 2016.09.19
  • Published : 2017.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Much of the attention of tuberculosis (TB) programs is focused on outcomes of microbiological cure and mortality, and health related quality of life (HRQL) is undervalued. Also, TB patients have a significantly higher risk of developing depression and anxiety compared with those in the general population. We intend to evaluate the HRQL and the prevalence of symptoms of depression and anxiety in hospitalized patients with TB. Methods: Cross-sectional study in a tertiary care hospital in Brazil. Adult patients with pulmonary TB that were hospitalized during the study period were identified and invited to participate. HRQL was measured using the Medical Outcomes Study Short Form-36 (SF-36) version 2. Hospital Anxiety and Depression Scale (HADS) was used to record symptoms of anxiety and depression. Results: Eighty-six patients were included in the analysis. The mean age of all patients was $44.6{\pm}15.4$ years, 69.8% were male, and 53.5% were white. Thirty-two patients (37.2%) were human immunodeficiency virus positive. Twenty-seven patients (31.4%) met study criteria for depression (HADS depression score ${\geq}11$) and 33 (38.4%) had anxiety (HADS anxiety score ${\geq}11$). Scores on all domains of SF-36 were significantly lower than the Brazilian norm scores (p<0.001). Conclusion: The present study shows that TB patients may have a poor HRQL. Additionally, we found a possible high prevalence of depression and anxiety in this population. Health care workers should be aware of these psychological disorders to enable a better management of these patients. The treatment of these comorbidities may be associated with better TB outcomes.

Keywords

References

  1. Secretaria de Vigilancia em Saude, Ministerio da Saude. Boletim Epidemiologico [Internet]. Brasilia: Portal de Saude, Ministerio da Saude; 2015 [cited 2016 Oct 1]. Available from: http://www.saude.gov.br.
  2. Guo N, Marra CA, Marra F, Moadebi S, Elwood RK, Fitzgerald JM. Health state utilities in latent and active tuberculosis. Value Health 2008;11:1154-61. https://doi.org/10.1111/j.1524-4733.2008.00355.x
  3. Marra CA, Marra F, Colley L, Moadebi S, Elwood RK, Fitzgerald JM. Health-related quality of life trajectories among adults with tuberculosis: differences between latent and active infection. Chest 2008;133:396-403. https://doi.org/10.1378/chest.07-1494
  4. Keshavjee S, Gelmanova IY, Farmer PE, Mishustin SP, Strelis AK, Andreev YG, et al. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet 2008;372:1403-9. https://doi.org/10.1016/S0140-6736(08)61204-0
  5. Long NH, Johansson E, Diwan VK, Winkvist A. Fear and social isolation as consequences of tuberculosis in VietNam: a gender analysis. Health Policy 2001;58:69-81. https://doi.org/10.1016/S0168-8510(01)00143-9
  6. Miller TL, McNabb SJ, Hilsenrath P, Pasipanodya J, Weis SE. Personal and societal health quality lost to tuberculosis. PLoS One 2009;4:e5080. https://doi.org/10.1371/journal.pone.0005080
  7. Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med 2003;167:1472-7. https://doi.org/10.1164/rccm.200206-626OC
  8. Shen TC, Wang CY, Lin CL, Liao WC, Chen CH, Tu CY, et al. People with tuberculosis are associated with a subsequent risk of depression. Eur J Intern Med 2014;25:936-40. https://doi.org/10.1016/j.ejim.2014.10.006
  9. Pachi A, Bratis D, Moussas G, Tselebis A. Psychiatric morbidity and other factors affecting treatment adherence in pulmonary tuberculosis patients. Tuberc Res Treat 2013;2013:489865.
  10. Doherty AM, Kelly J, McDonald C, O'Dywer AM, Keane J, Cooney J. A review of the interplay between tuberculosis and mental health. Gen Hosp Psychiatry 2013;35:398-406. https://doi.org/10.1016/j.genhosppsych.2013.03.018
  11. Sulehri MA, Dogar IA, Sohail H, Mehdi Z, Azam M, Niaz O, et al. Prevalence of depression among tuberculosis patients. APMC 2010;4:133-7.
  12. Aghanwa HS, Erhabor GE. Demographic/socioeconomic factors in mental disorders associated with tuberculosis in southwest Nigeria. J Psychosom Res 1998;45:353-60. https://doi.org/10.1016/S0022-3999(98)00006-3
  13. Conde MB, Melo FA, Marques AM, Cardoso NC, Pinheiro VG, Dalcin Pde T, et al. III Brazilian Thoracic Association guidelines on tuberculosis. J Bras Pneumol 2009;35:1018-48. https://doi.org/10.1590/S1806-37132009001000011
  14. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000;161(4 Pt 1):1376-95. https://doi.org/10.1164/ajrccm.161.4.16141
  15. Ciconelli RM, Ferraz MB, Santos W, Meinao I, Quaresma MR. Brazilian-Portuguese version of the SF-36: a reliable and valid quality of life outcome measure. Rev Bras Reumatol 1999;39:143-50.
  16. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey: manual and interpretation guide. Lincoln: Quality Metric; 2005. p. 1-38.
  17. Laguardia J, Campos MR, Travassos C, Najar AL, Anjos LA, Vasconcellos MM. Brazilian normative data for the Short Form 36 questionnaire, version 2. Rev Bras Epidemiol 2013;16:889-97. https://doi.org/10.1590/S1415-790X2013000400009
  18. Fang CT, Hsiung PC, Yu CF, Chen MY, Wang JD. Validation of the World Health Organization quality of life instrument in patients with HIV infection. Qual Life Res 2002;11:753-62. https://doi.org/10.1023/A:1020870402019
  19. Fleck MP, Louzada S, Xavier M, Chachamovich E, Vieira G, Santos L, et al. Application of the Portuguese version of the abbreviated instrument of quality life WHOQOL-bref. Rev Saude Publica 2000;34:178-83. https://doi.org/10.1590/S0034-89102000000200012
  20. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
  21. Botega NJ, Bio MR, Zomignani MA, Garcia C Jr, Pereira WA. Mood disorders among inpatients in ambulatory and validation of the anxiety and depression scale HAD. Rev Saude Publica 1995;29:355-63.
  22. Hutz CS, Zanon C. Revision of the adaptation, validation, and normatization of the Roserberg self-esteem scale. Aval Psicol 2011;10:41-9.
  23. Aamir S, Aisha. Co-morbid anxiety and depression among pulmonary tuberculosis patients. J Coll Physicians Surg Pak 2010;20:703-4.
  24. World Health Organization. WHO definition of health [Internet]. Geneva: World Health Organization; 2015 [cited 2016 Oct 1]. Available from: http://www.who.int.
  25. Westaway MS, Wolmarans L. Depression and self-esteem: rapid screening for depression in black, low literacy, hospitalized tuberculosis patients. Soc Sci Med 1992;35:1311-5. https://doi.org/10.1016/0277-9536(92)90184-R
  26. vonAmmon Cavanaugh S. The prevalence of emotional and cognitive dysfunction in a general medical population: using the MMSE, GHQ, and BDI. Gen Hosp Psychiatry 1983;5:15-24. https://doi.org/10.1016/0163-8343(83)90038-5
  27. Schechter M, Zajdenverg R, Falco G, Barnes GL, Faulhaber JC, Coberly JS, et al. Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts. Am J Respir Crit Care Med 2006;173:922-6. https://doi.org/10.1164/rccm.200512-1953OC
  28. Ugarte-Gil C, Ruiz P, Zamudio C, Canaza L, Otero L, Kruger H, et al. Association of major depressive episode with negative outcomes of tuberculosis treatment. PLoS One 2013;8:e69514. https://doi.org/10.1371/journal.pone.0069514
  29. Rose N, Shang H, Pfyffer GE, Brandli O. Tuberculosis therapy in canton Zurich 1991-1993: what are the causes for recurrence and therapy failure? Schweiz Med Wochenschr 1996;126:2059-67.
  30. Tidey JW, Miller ME. Smoking cessation and reduction in people with chronic mental illness. BMJ 2015;351:h4065.
  31. Luger TM, Suls J, Vander Weg MW. How robust is the association between smoking and depression in adults? A metaanalysis using linear mixed-effects models. Addict Behav 2014;39:1418-29. https://doi.org/10.1016/j.addbeh.2014.05.011
  32. Gajalakshmi V, Peto R, Kanaka TS, Jha P. Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet 2003;362:507-15. https://doi.org/10.1016/S0140-6736(03)14109-8
  33. Slama K, Chiang CY, Enarson DA, Hassmiller K, Fanning A, Gupta P, et al. Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis 2007;11:1049-61.
  34. Adejumo O, Oladeji B, Akpa O, Malee K, Baiyewu O, Ogunniyi A, et al. Psychiatric disorders and adherence to antiretroviral therapy among a population of HIV-infected adults in Nigeria. Int J STD AIDS 2016;27:938-49. https://doi.org/10.1177/0956462415600582
  35. van den Heuvel L, Chishinga N, Kinyanda E, Weiss H, Patel V, Ayles H, et al. Frequency and correlates of anxiety and mood disorders among TB- and HIV-infected Zambians. AIDS Care 2013;25:1527-35. https://doi.org/10.1080/09540121.2013.793263

Cited by

  1. The Mediating Effects of Stigma on Depressive Symptoms in Patients With Tuberculosis: A Structural Equation Modeling Approach vol.9, pp.None, 2017, https://doi.org/10.3389/fpsyt.2018.00618
  2. Depressive Symptoms Mediate the Associations of Stigma with Medication Adherence and Quality of Life in Tuberculosis Patients in China vol.100, pp.1, 2017, https://doi.org/10.4269/ajtmh.18-0324
  3. Prevalence of Depressive Symptoms and Associated Factors among Internal Migrants with Tuberculosis: A Cross-Sectional Study in China vol.102, pp.1, 2020, https://doi.org/10.4269/ajtmh.19-0542
  4. The prevalence of depression among patients with tuberculosis: a systematic review and meta-analysis vol.19, pp.1, 2017, https://doi.org/10.1186/s12991-020-00281-8
  5. Comorbidities between tuberculosis and common mental disorders: a scoping review of epidemiological patterns and person-centred care interventions from low-to-middle income and BRICS countries vol.9, pp.1, 2017, https://doi.org/10.1186/s40249-019-0619-4
  6. Prevalence and Correlates of Anxiety and Depressive Symptoms in Patients With and Without Multi-Drug Resistant Pulmonary Tuberculosis in China vol.12, pp.None, 2017, https://doi.org/10.3389/fpsyt.2021.674891
  7. Prevalence of depressive symptoms and related risk factors in Japanese patients with pulmonary nontuberculous mycobacteriosis vol.26, pp.9, 2017, https://doi.org/10.1080/13548506.2020.1808235
  8. Tuberculosis-related stigma and its determinants in Dalian, Northeast China: a cross-sectional study vol.21, pp.1, 2021, https://doi.org/10.1186/s12889-020-10055-2
  9. Tuberculosis related disability: a systematic review and meta-analysis vol.19, pp.1, 2017, https://doi.org/10.1186/s12916-021-02063-9